Long circulating half‐life and high tumor selectivity of the photosensitizer meta‐tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma
暂无分享,去创建一个
Hubert van den Bergh | Martin Forrer | Thomas Glanzmann | Philippe Monnier | Snezana Andrejevic | P. Monnier | G. Wagnières | T. Glanzmann | D. Braichotte | M. Forrer | J. Mach | S. Folli | Patrick Westermann | Daniel R. Braichotte | Georges A. Wagnieres | Jean‐Pierre Mach | Silvio Folli | S. Andrejevic | H. E. van den Bergh | P. Westermann
[1] H Lenz,et al. Measurements on the depth of penetration of light (0.35–1.0 µm) in tissue , 1977, Radiation and environmental biophysics.
[2] G. Wagnières,et al. Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi , 1995, Cancer.
[3] Y. Barenholz,et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. , 1994, Cancer research.
[4] Daniel Braichotte,et al. Clinical pharmacokinetic studies of tetra(meta‐hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths , 1995, International journal of cancer.
[5] T. Berg,et al. Uptake, intracellular transport, and degradation of polyethylene glycol-modified asialofetuin in hepatocytes. , 1992, The Journal of biological chemistry.
[6] T. Dougherty,et al. CARBON‐14 LABELING AND BIOLOGICAL ACTIVITY OF THE TUMOR‐LOCALIZING DERIVATIVE OF HEMATOPORPHYRIN , 1988, Photochemistry and photobiology.
[7] F. Buchegger,et al. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments. , 1989, The Journal of clinical investigation.
[8] M C Berenbaum,et al. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. , 1989, The Biochemical journal.
[9] H. Altermatt,et al. Photodynamic therapy with m‐tetrahydroxyphenylchlorin in vivo: Optimization of the therapeutic index , 1993, International journal of cancer.
[10] M. Siciliano,et al. Longitudinal karyotype and genetic signature analysis of cultured human colon adenocarcinoma cell lines LS180 and LS174T. , 1980, Cancer research.
[11] R. Veenhuizen,et al. Intraperitoneal photodynamic therapy in the rat: Comparison of toxicity profiles for photofrin and mTHPC , 1994, International journal of cancer.
[12] J Moan,et al. PHOTOCHEMOTHERAPY OF CANCER: EXPERIMENTAL RESEARCH , 1992, Photochemistry and photobiology.
[13] F. Martin,et al. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid , 1992, International journal of cancer.
[14] C. Gomer. PRECLINICAL EXAMINATION OF FIRST and SECOND GENERATION PHOTOSENSITIZERS USED IN PHOTODYNAMIC THERAPY , 1991, Photochemistry and photobiology.
[15] T. Hasan,et al. Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. , 1994, British Journal of Cancer.
[16] U Althaus,et al. Effect of drug‐light interval on photodynamic therapy with meta‐tetrahydroxyphenylchlorin in malignant mesothelioma , 1993, International journal of cancer.
[17] M C Berenbaum,et al. In vivo biological activity of the components of haematoporphyrin derivative. , 1982, British Journal of Cancer.
[18] L. Rudel,et al. Characterization of plasma lipoproteins separated and purified by agarose-column chromatography. , 1974, The Biochemical journal.
[19] R. Anderson,et al. TRANSMITTANCE OF NONIONIZING RADIATION IN HUMAN TISSUES * , 1981, Photochemistry and photobiology.
[20] T. Dougherty,et al. HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.
[21] C. Heusser,et al. Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] T J Dougherty,et al. PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.
[23] P. Monnier,et al. Photofrin II Pharmacokinetics and Optical Dosing in Tissue: Apparatus and Clinical Measurements for the Pharynx, Esophagus, and Tracheobronchial Tree , 1991 .
[24] M. C. Berenbaum,et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. , 1991, British journal of cancer.
[25] F. Buchegger,et al. Tumor‐necrosis factor can enhance radio‐antibody uptake in human colon carcinoma xenografts by increasing vascular permeability , 1993, International journal of cancer.
[26] B. Wilson,et al. Light propagation in animal tissues in the wavelength range 375-825 nanometers. , 1984, Progress in clinical and biological research.
[27] H. van den Bergh,et al. Antibody–fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice , 1991, Cancer.
[28] H. Barr,et al. Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma. , 1987, British Journal of Cancer.
[29] J. Moan,et al. Tissue distribution of 3H-hematoporphyrin derivative and its main components, 67Ga and 131I-albumin in mice bearing Lewis lung carcinoma. , 1984, Progress in clinical and biological research.
[30] H. Oppelaar,et al. Photosensitizing efficacy of MTHPC‐PDT compared to Photofrin‐PDT in the RIF1 mouse tumour and normal skin , 2006, International journal of cancer.
[31] J Moan,et al. Evaluation of a new photosensitizer, meso‐tetra‐hydroxyphenyl‐chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers , 1994, International journal of cancer.